CD79A and irritable bowel syndrome: Subgroup analysis of CD prevalence based on serology test (anti tTG-IgA) showed that the difference in subgroup analysis for IBS (p = 0.162) and year of study (p = 0.117) and quality of study was not significant (Table 2).